We are live on
!
Find out more
LVTX
LAVA Therapeutics
LVTX
LVTX
Delisted
LVTX was delisted on the 20th of November, 2025.
14 hedge funds and large institutions have $8.47M invested in LAVA Therapeutics in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.1% less ownership
Funds ownership: 21.86% → 21.75% (-0.1%)
7% less funds holding
Funds holding: 15 → 14 (-1)
27% less capital invested
Capital invested by funds: $11.7M → $8.47M (-$3.2M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
1
Calls
$25K
Puts
–
Net Calls
+$25K
Net Calls Change
-$10K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$179 |
Top Sellers
| 1 |
Millennium Management
New York
|
-$29.3K |
| 2 |
HF
HRT Financial
New York
|
-$21K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$837 |